6 Ways Nanobodies Can Transform Therapeutic Development
Reflecting on Traditional Therapeutics I’ve spent over 20 years in the pharmaceutical field, and one thing remains clear: traditional antibodies often come with a complex set of issues. High costs, lengthy development times, and limited efficacy can frustrate even the most seasoned professionals. This reality begs the question—how can we enhance therapeutic options for patients